Bio-Connect
WB analysis of recombinant anthrax LF protein using GTX13814 Bacillus anthracis Lethal Factor antibody [5F502.2]. Dilution : 0.1 microg/ml
WB analysis of recombinant anthrax LF protein using GTX13814 Bacillus anthracis Lethal Factor antibody [5F502.2]. Dilution : 0.1 microg/ml
WB analysis of recombinant anthrax LF protein using GTX13814 Bacillus anthracis Lethal Factor antibody [5F502.2]. Dilution : 0.1 microg/ml

Bacillus anthracis Lethal Factor antibody [5F502.2]

GTX13814
GeneTex
ApplicationsWestern Blot
Product group Antibodies
ReactivityBacteria
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    Bacillus anthracis Lethal Factor antibody [5F502.2]
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 0.1 - 1 microg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    5F502.2
  • Concentration
    0.5 mg/ml
  • Conjugate
    Unconjugated
  • Host
    Mouse
  • Isotype
    IgG1
  • Scientific Description
    Anthrax PA (Protective Antigen) and Anthrax LF (Lethal Factor), along with Anthrax EF (Edema Factor), are toxins produced by Bacillus anthracis. All three of the proteins must be present for toxicity to occur. It begins with the binding of PA to its cell-surface receptor, ATR (Anthrax Toxin Receptor), at which point PA is cleaved and the resulting 63 kD carboxyl-terminal fragment binds to LF and EF. LF is a protease that is known to cleave members of the mitogen-activated protein kinase kinase (MAPKK) family.
  • Reactivity
    Bacteria
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203